ArticleInternational journal of chronic obstructive pulmonary disease2025
The Cross-Sectional Area of Erector Spinae Muscles Obtained from Chest CT Is an Independent Predictor of Death in COPD.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The lung-muscle axis in COPD: a conceptual framework integrating evidence, mechanisms, and therapeutic perspectives.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: Skeletal muscle loss usually predicts poor clinical outcomes in patients with chronic obstructive pulmonary disease (COPD). However, the prognostic value of erector spinae muscle (ESM) in COPD remains unclear. Methods: The cross-sectional area of ESM (ESMCSA) was retrospectively measured on a single-slice axial image obtained from chest computed tomography of COPD patients. The clinical characteristics and 5-year all-cause mortality of these patients were recorded. Results: The ESMCSA of COPD patients in the non-survivor group was significantly lower than that in the survivor group (P<0.001). Decreased ESMCSA was significantly correlated with pulmonary function decline (P<0.001). The threshold of ESMCSA to predict the 5-year all-cause mortality of COPD was 23.42cm Conclusion: ESMCSA is a significant predictor for 5-year all-cause mortality in COPD patients, and the nomogram model based on ESMCSA has a certain reference value for predicting COPD prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.